
Sign up to save your podcasts
Or
This episode is shared from Mayo Clinic Q&A and was recorded in November 3, 2021
Guest: Elie F. Berbari, M.D.
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
In anticipation of more COVID-19 vaccine approvals this week, Dr. Elie Berbari, chair of the Division of Infectious Diseases at Mayo Clinic, says it's good news that younger children will now have more protection against COVID-19.
"It's important that we reach a very high level of vaccination rates to achieve kind of a wall of immunity that could prevent transmission and prevent us from these repeated peaks that we've been dealing with over the last year and a half during this pandemic," says Dr. Berbari.
In this Mayo Clinic Q&A podcast, Dr. Berbari also talks about the rare cases of myocarditis and how the Food and Drug Administration is monitoring those cases. Dr. Berbari also addresses additional COVID-19 vaccine doses for immunocompromised people, the importance of masking, even if vaccinated, and he answers a number of listener questions.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
4.4
259259 ratings
This episode is shared from Mayo Clinic Q&A and was recorded in November 3, 2021
Guest: Elie F. Berbari, M.D.
Host: Halena M. Gazelka, M.D. (@hmgazelkamd)
In anticipation of more COVID-19 vaccine approvals this week, Dr. Elie Berbari, chair of the Division of Infectious Diseases at Mayo Clinic, says it's good news that younger children will now have more protection against COVID-19.
"It's important that we reach a very high level of vaccination rates to achieve kind of a wall of immunity that could prevent transmission and prevent us from these repeated peaks that we've been dealing with over the last year and a half during this pandemic," says Dr. Berbari.
In this Mayo Clinic Q&A podcast, Dr. Berbari also talks about the rare cases of myocarditis and how the Food and Drug Administration is monitoring those cases. Dr. Berbari also addresses additional COVID-19 vaccine doses for immunocompromised people, the importance of masking, even if vaccinated, and he answers a number of listener questions.
AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
135 Listeners
315 Listeners
497 Listeners
688 Listeners
258 Listeners
3,323 Listeners
90 Listeners
26 Listeners
1,103 Listeners
195 Listeners
516 Listeners
349 Listeners
12 Listeners
18 Listeners
251 Listeners
15 Listeners
9 Listeners
427 Listeners
367 Listeners
46 Listeners
14 Listeners